fbpx

In: point of care

27 MayADEXUSDx COVID-19 Antibody Test Receives FDA Emergency Use Authorization for Point-of-Care Deployment Across U.S.


SPRINGDALE, AR, May 25, 2021 – NOWDiagnostics, Inc. announced today that it has received Emergency Use Authorization (EUA) for its ADEXUSDx® COVID-19…

Read More

28 JulADEXUSDx® COVID-19 Test receives Conformité Européene (CE) mark approval


ADEXUSDx COVID-19 Test receives Conformité Européene (CE) mark approval We are proud to announce that our ADEXUSDx COVID-19 antibody test has…

Read More

26 JunIntroducing the ADEXUSDx COVID-19 Test


Introducing the ADEXUSDx COVID-19 Test At NOWDiagnostics, we’re always looking for ways to respond to community needs. Our new, rapid ADEXUSDx…

Read More

16 JunNOWDx seeks FDA Emergency Use Authorization (EUA) for COVID-19 Test


NOWDx seeks FDA Emergency Use Authorization (EUA) for COVID-19 Test The ADEXUSDx® COVID-19 Test is a rapid serology test that detects total antibodies…

Read More
POCT

26 OctPoint of Care Testing: What it Means and Why You Should Know


What’s the Definition of “Point of Care Testing?” The phrase “point of care testing” is used often in healthcare, but what…

Read More